If you or someone you know is in crisis, confidential support is available.
Read the Latest News
Drawing on current research and clinical expertise, these articles address emerging trends, treatment considerations, and the complexities of care across the reproductive lifespan.
For women who require treatment with quetiapine during pregnancy, the available reproductive safety data are generally reassuring. The largest body of evidence does not suggest a meaningful increase in major congenital malformations, while metabolic effects, particularly gestational diabetes, remain an important consideration.
Suicide risk during pregnancy and the postpartum, use of modafinil in pregnancy, and new treatment for menopausal symptoms are featured in this week’s roundup.
A new study examines pregnancy outcomes among women using stimulants or atomoxetine during pregnancy, finding modest increases in some complications with stimulant use while highlighting important limitations of observational data.
Sign up for our newsletter
Get the latest news in women’s mental health and our research.
"*" indicates required fields
